SPONSOR
University Hospital, Bonn
Total Trials
7
Recruiting
7
Phases
Phase 2
Conditions studied: Lung Cancer Non-Small Cell Cancer (NSCLC)Sarcopenia in ElderlyImmunophenotyping Blood Samples of Patients With OsteoporosisLiver CirrhosisLiver CirrhosesPeriprosthetic Hip InfectionACL - Anterior Cruciate Ligament Rupture
University Hospital, Bonn is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Lung Cancer Non-Small Cell Cancer (NSCLC), Sarcopenia in Elderly, Immunophenotyping Blood Samples of Patients With Osteoporosis, Liver Cirrhosis.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University Hospital, Bonn
How many clinical trials has University Hospital, Bonn sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by University Hospital, Bonn, of which 7 are actively recruiting participants. These trials cover conditions including Lung Cancer Non-Small Cell Cancer (NSCLC), Sarcopenia in Elderly, Immunophenotyping Blood Samples of Patients With Osteoporosis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University Hospital, Bonn research focus on?
University Hospital, Bonn clinical trials span Lung Cancer Non-Small Cell Cancer (NSCLC), Sarcopenia in Elderly, Immunophenotyping Blood Samples of Patients With Osteoporosis, Liver Cirrhosis, Liver Cirrhoses, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University Hospital, Bonn clinical trial?
To participate in a University Hospital, Bonn trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Hospital, Bonn trials with current recruitment status updated daily.
Clinical Trials by University Hospital, Bonn
NCT06810609 Phase 2
Recruiting
Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC
Lung Cancer Non-Small Cell Cancer (NSCLC)
NCT07291765
Recruiting
Blood Flow Restriction Training in Acute Geriatric Rehabilitation
Sarcopenia in Elderly
NCT05132348
Recruiting
Immunophenotyping in Patients With Osteoporosis
Immunophenotyping Blood Samples of Patients With Osteoporosis
NCT03584204
Recruiting
Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and Outcome
Liver Cirrhosis
NCT03746210
Recruiting
Non-Invasive Characterization of Focal Liver Lesions in Liver Cirrhosis
Liver Cirrhoses
NCT07299591
Recruiting
Analysis of Pharmacological Aspects Regarding Infection Free Survival After Surgical Treatment of a Periprosthetic Hip Infection: a Microdialysis Study
Periprosthetic Hip Infection
NCT07043569
Recruiting
Clinical-randomized Trial of the Effect of Rehabilitation Therapy Using Strength and Blood Flow Restriction Training on Muscular Fitness and Regeneration After Anterior Cruciate Ligament Reconstruction
ACL - Anterior Cruciate Ligament Rupture
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology